At a glance
ClinicalIndex Comparison RecordPhase 4Completed· 528 enrolled
Drug / intervention
CeraVe Hydrating Cleanser +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Clinical Evaluation of CeraVe Hydrating Cleanser and Moisturizing Cream for the Improvement of Skin Condition in Patients With Diabetes Mellitus (DM) Related Skin Changes
In Brief
A Phase 4 clinical trial evaluating CeraVe Hydrating Cleanser and CeraVe Moisturizing Cream for Diabetes Complications. Completed, enrolled 528 participants across 1 site.
Detailed Summary
The purpose of this study is to evaluate the safety and efficacy of the CeraVe Diabetic Skin Line for the improvement of skin condition in patients with diabetes mellitus.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsDiabetes Complications
CountriesUnited States
CollaboratorsCeraVe
Timeline
Phase 4CompletedFinished
202120222023202420252026
First PostedJan 2021
Enrollment StartMar 2021
Primary CompletionAug 2021
TodayJul 2026
First PostedJan 26, 2021
Enrollment StartMar 12, 2021
Primary CompletionAug 10, 2021
TodayJul 2, 2026
Enrollment to primary: 5 monthsPosted 5.4 years ago
Interventions
CeraVe Hydrating Cleanserdrug
topical cleanser applied twice a day for 28 days
CeraVe Moisturizing Creamdrug
topical cream applied twice a day for 28 days